| 000 | 01759 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516142939.0 | ||
| 264 | 0 | _c20131022 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1347-5223 | ||
| 024 | 7 |
_a10.1248/cpb.c12-00993 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbadi, Ashraf Hassan | |
| 245 | 0 | 0 |
_aModulating the cyclic guanosine monophosphate substrate selectivity of the phosphodiesterase 3 inhibitors by pyridine, pyrido[2,3-d]pyrimidine derivatives and their effects upon the growth of HT-29 cancer cell line. _h[electronic resource] |
| 260 |
_bChemical & pharmaceutical bulletin _c2013 |
||
| 300 |
_a405-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic Nucleotide Phosphodiesterases, Type 3 _xchemistry |
| 650 | 0 | 4 | _aCyclization |
| 650 | 0 | 4 | _aHT29 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aPhosphodiesterase 3 Inhibitors _xchemistry |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 |
_aPyrimidines _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aHany, Marwa Saeed | |
| 700 | 1 | _aElsharif, Shimaa Awadain | |
| 700 | 1 | _aEissa, Amal Abdel Haleem | |
| 700 | 1 | _aGary, Bernard Dewayne | |
| 700 | 1 | _aTinsley, Heather Nicole | |
| 700 | 1 | _aPiazza, Gary Anthony | |
| 773 | 0 |
_tChemical & pharmaceutical bulletin _gvol. 61 _gno. 4 _gp. 405-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/cpb.c12-00993 _zAvailable from publisher's website |
| 999 |
_c22631063 _d22631063 |
||